Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 42 (RPL7P42)

Target
RPL7P42
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L7 pseudogene 42 (RPL7P42) is a processed pseudogene, meaning it is a nonfunctional genomic DNA sequence derived from the functional ribosomal protein L7 gene (RPL7)[3][6]. Pseudogenes like RPL7P42 do not encode functional proteins and typically do not have direct biological activity, therapeutic targeting utility, or disease associations. The parent gene, RPL7, encodes a component of the 60S ribosomal subunit, but the pseudogenes are generally considered "genomic fossils" without protein-coding capacity or druggability[6]. As such, ribosomal protein L7 pseudogene 42 is not recognized as a therapeutic target, nor does it have known aliases, biological functions, disease associations, or drug interactions relevant to clinical or pharmacological fields[3][6]. Additional notes: - This is a non-functional pseudogene, not a protein, receptor, or drug target. - The biological and disease roles, mechanisms of action, and related features apply only to the canonical, functional RPL7 gene and not to its pseudogenes. - There is nothing intrinsically "wrong" with the spelling or synonym, but as a pseudogene it is not an actionable therapeutic target.

Other names
RPL7_22_1255

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 42 (RPL7P42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 42 (RPL7P42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call